Medical mycology

Mycological Research

Volumn 100, Issue 10, 1996, Pages 1153-1162

  Warnock, David W ^a   Campbell, Colin K ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030320297     PISSN: 09537562     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-7562(96)80175-4     Document Type: Review

References (107)

1. Adler-Moore, J P. & Proffitt, R. T. (1993). Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. Journal of Liposomal Research 3, 429-450.
2. Ajello, L. (1986). Hyalohyphomycosis and phaeohyphomycosis: two global disease entities of public health importance. European Journal of Epidemiology 2, 243-251.
3. Banerjee, S. N., Emori, G, Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T. et al. (1991). Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1999. American Journal of Medicine 91, supplement 3B, 86-89.
4. Barnes, R. A. & Rogers, T. R. (1969). Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. Journal of Hospital Infection 14, 89-94
5. Bart-Delabesse, E , Boiron, P , Carlotti, A. & Dupont, B. (1993). Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. Journal of Clinical Microbiology 31, 2933-2937.
6. Birch, M., Anderson, M J. & Denning, D. W (1995) Molecular typing of Aspergillus species. Journal of Hospital Infection 30, supplement, 339-351.
7. Birley, H. D. L., Johnson, E. M., McDonald P., Parry, C , Carey, P. B. & Warnock, D. W. (1995). Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis International Journal of STD and AIDS 6, 353-355.
8. Bodey, G. P., Buckley, M., Sathe, Y. S. & Freireich, E. J. (1966). Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Journal of Chronic Diseases 19, 667-687.
9. Bodey, G. P., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M. et al. (1992). Fungal infections in cancer patients: an international autopsy survey. European Journal of Clinical Microbiology and Infectious Diseases 11, 99-109.
10. Boerlin, P., Addo, M., Boerlin-Petzold, F., Durussel, C., Pagani, J.-L., Chave, J -P. et al. (1995). Transmission of oral Candida albicans strains between HIV-positive patients. Lancet 345, 1052-1053.
11. Burnie, J P. (1986). Candida and hands. Journal of Hospital Infection 8, 1-4.
12. Burnie, J. P. & Matthews, R. C. (1991). Heat-shock protein 88 and aspergillus infection. Journal of Clinical Microbiology 29, 2099-2106.
13. Butler, W. T., Bennett, J. E., Alling, D. & Wertlake, P. T (1964). Nephrotoxicity of amphotericin B: early and late effects in 81 patients. Annals of Internal Medicine 61, 175-187.
14. Campbell, C. K. & Mulder, J L (1977). Skin and nail infection by Scytalidium hyalinum sp. nov. Sabouraudia 15, 161-166.
15. Carlier, G. I. M. (1963). A seventeen year survey of the ringworm flora of Birmingham. Journal of Hygiene, Cambridge 61, 291-305.
16. Chandrasekar, P. H., Gatny, C. M. & The Bone Marrow Transplantation Team (1994). The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients Journal of Antimicrobial Chemotherapy 33, 309-318.
17. Crampin, A C & Matthews, R. C. (1993) Application of the polymerase chain reaction to the diagnosis if candidosis by amplification of an HSP 90 gene fragment. Journal of Medical Microbiology 39, 223-238.
18. Currie, B. P., Freundlich, L. F. & Casadevall, A. (1994). Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. Journal of Clinical Microbiology 32, 1188-1192.
19. Deng, Z L., Ribas, J L., Gibson, D. W. & Connor, D H. (1988) Infections caused by Penicillum marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Reviews of Infectious Diseases 10, 640-652
20. Denning, D. W., Lee, J. Y., Hostetler, J. S , Pappas, P., Kauffman, C. A., Dewsnup, D. H et al. (1994) NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis American Journal of Medicine 97, 135-144
21. de Repentigny, L. (1992). Serodiagnosis of candidiasis, aspergillosis and cryptococcosis. Clinical Infectious Diseases 14, supplement 1, S11-S22.
22. DiSalvo, A F., Fickling, A. M & Ajello, L. (1973). Infection caused by Penicillium marneffei: Description of the first natural infection in man. American Journal of Clinical Pathology 60, 259-263.
23. Doebbeling, B N , Hollis, R. J., Isenberg, H. D., Wenzel, R. P. & Pfaller, M. A (1991). Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infections. Journal of Clinical Microbiology 29, 1268-1270
24. Drouhet, E. (1993). Penicilliosis due to Penicillium mameffei: a new emerging systemic mycosis in AIDS patients travelling or living in Southeast Asia. Journal de Mycologie Medicale 3, 195-224
25. Dupont, B. (1988) Antigen detection in invasive aspiergillosis. In Fungal Antigens. Isolation, Purification and Detection (ed. E. Drouhet, G. T. Cole, L. de Repentigny, J.-P. Latge & B. Dupont), pp. 367-375. Plenum Press: New York.
26. Elewski, B. E. & Greer, D. L. (1991). Hendersanula toruloidea and Scytalidium hyalinum: review and update. Archives of Dermatology 127, 1041-1044.
27. Ellis, D. H. & Pfeiffer, T. J. (1990). Natural habitat of Cryptococcus neaformans var. gatti. Journal of Clinical Microbiology 28, 1642-1644
28. English, M. P. & Lewis, L. (1974). Ringworm in the south west of England, 1960-1970, with special reference to onychomycosis. British Journal of Dermatology 90, 67-75.
29. Evans, E. G. V., Richardson, M. D., Odds, F. C. & Holland, K. T. (1973). Relevance of antigenicity of Candida albicans growth phases to diagnosis of systemic candidiasis British Medical Journal iv, 80-87.
30. Finkelstein, R., Reinhartz, G., Hashman, N. & Merzbach, D (1993). Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit. Infection Control and Hospital Epidemiology 14, 587-590.
31. Franklyn, K. M. & Warmington, J R (1993). Cloning and nucleotide sequence analysis of the Candida albicans enolase gene. FEMS Microbiology Letters 111, 101-108
32. Franklyn, K. M., Warmington, J. R., Ott, A. K. & Ashman, R B. (1990). An immunodominant antigen of Candida albicans shows homology to the enzyme enolase. Immunology and Cell Biology 68, 173-178
33. Garnis, A. S., Gudnason, T., Giebink, G. S. & Ramsay, N. K C (1991). Disseminated infection with fusarium in recipients of bone marrow transplants. Reviews of Infectious Diseases 13, 1077-1008
34. Gentles, J. C. (1958) Experimental ringworm in guineapigs: oral treatment with griseofulvin. Nature 183, 256-257.
35. Gentles, J. C. & Evans, E. G. V. (1970). Infection of the feet and nails with Hendersonula toruloidea Sabouraudia 8, 72-75.
36. Georgopapadakou, N. H & Walsh, T. J. (1996). Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrobial Agents and Chemotherapy 40, 279-291.
37. Gerson, S. L., Talbot G. H , Hurwitz, S , Strom, B. L., Lusk, E. J. & Cassileth, P A. (1984) Prolonged granulocytopenia : the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Annals of Internal Medicine 100, 345-351
38. Girardin, H , Latge, J. P., Srikantha, T., Morrow, B & Soll, D. R. (1993). Development of DNA probes for fingerprinting Aspergillus fumigatus. Journal of Clinical Microbiology 31, 1547-1554
39. Girardin, H , Sarfati, J., Traore, F., Dupouy Camet, J., Derouin, F. & Latge, J. P. (1994). Molecular epidemiology of nosocomial invasive aspergillosis. Journal of Clinical Microbiology 32, 684-690.
40. Girmenia, C., Arcese, W., Micozzi, A., Martino, P., Bianco, P & Morace, G. (1992). Onychomycosis as a possible origin of disseminated Fusarium solani infection in a patient with severe aplastic anaemia. Clinical Infectious Diseases 14, 1167.
41. Goodfield, M J. D., Andrew, L. & Evans, E. G. V (1992). Short term treatment of dermatophyte onychomycosis with terbinafine British Medical Journal 304, 1151-1154.
42. Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaiser, H. et al. (1992). A controlled trial of fluconazole to prevent fungal infection in patients undergoing bone marrow transplantation. New England Journal of Medicine 326, 845-851.
43. Graybill, J. R. (1992) Future directions of antifungal chemotherapy. Clinical Infectious Diseases 14, supplement 1, S170-S181.
44. Hay, R. J. (1992). Treatment of dermatomycoses and onychomycoses state of the art Clinical and Experimental Dermatology 17, supplement 1, 2-5.
45. Hay, R. J., Mackenzie, D. W R., Campbell, C K. & Philpot, C. M. (1980). Cryptococcosis in the United Kingdom and the Irish Republic: an analysis of 69 cases. Journal of Infection 2, 13-22.
46. Haynes, K. A , Westerneng, T. J , Fell, J. W. & Moens, W (1995). Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA Journal of Medical and Veterinary Mycology 33, 319-325.
47. Hebert, A. A. (1988). Tinea capitis. Current concepts. Archives of Dermatology 124, 1554-1557.
48. Hibberd, P. L. & Rubin, R. H. (1994). Clinical aspects of fungal infection in organ transplant recipients. Clinical Infectious Diseases 19, supplement 1, S33-S40.
49. Hopfer, R L , Walden, P., Setterquist, S. & Highsmith, W. E. (1993). Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. Journal of Medical and Veterinary Mycology 31, 65-75.
50. Hopkins, C. C., Weber, D. J & Rubin, R H (1989). Invasive aspergilius infection: possible non-ward common source within the hospital environment Journal of Hospital Infection 13, 19-25.
51. Hopwood, V. & Evans, E. G. V (1991). Serological tests in the diagnosis and prognosis of fungal infection in the compromised patient. In Fungal Infection in the Compromised Patient (ed D W. Warnock & M D. Richardson), 2nd edn., pp. 311-353 Wiley: Chichester
52. Hopwood, V., Johnson, E M., Cornish, J. M , Foot, A. B. M., Evans, E G. V. & Warnock, D W. (1995). Use of the Pastorex aspergilius antigen latex agglutination test for the diagnosis of invasive aspergillosis. Journal of Clinical Pathology 48, 210-213.
53. Horsburgh, C. R. & Kirkpatrick, C. H (1933). Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole, experience with twenty-one patients. American Journal of Medicine 74, supplement 1B, 23-29.
54. Johnson, E. M., Davey, K G., Szekeley, A. & Warnock, D. W. (1995 a). Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species. Journal of Antimicrobial Chemotherapy 36, 787-793.
55. Johnson, E. M., Warnock, D W., Luker, J., Porter, S R. & Scully, C. (1995 b). Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Journal of Antimicrobial Chemotherapy 35, 103-114.
56. Karyotakis, N. C & Anaissie, E J (1994). The new antifungal azoles: fluconazole and itraconazole. Current Opinion in Infectious Diseases 7, 658-666.
57. Kauffman, C. A. (1994) Newer developments in therapy for endemic mycoses. Clinical Infectious Diseases 19, supplement 1, S28-S32.
58. Klein, R. S , Harris, C. A., Butkus Small, C., Moll, B., Lesser, M. & Friedland, G. H. (1984). Oral candidiasis in high risk patients as the initial manifestation of the acquired immune deficiency syndrome New England Journal of Medicine 311, 354-358
59. Lake-Bakaar, G., Scheuer, P J. & Sherlock, S (1987). Hepatic reactions associated with ketoconazole in the United Kingdom. British Medical Journal 294, 419-422.
60. Levitz, S. M. (1991). The ecology of Cryptococcus neoformans and the epidemiology of Cryptococcosis. Reviews of Infectious Diseases 13, 1163-1169.
61. Macdonald, F. & Odds, F. C. (1980). Purified Candida albicans proteinase in the serological diagnosis of systemic candidosis. Journal of the American Medical Association 243, 2409-2411.
62. Matsumoto, T., Ajello, L., Matsuda, T , Szaniszlo, P. J. & Walsh, T. J (1994) Developments in hyalohyphomycosis and phaeohyphomycosis. Journal of Medical and Veterinary Mycology 32, supplement 1, 329-349
63. Matthews, R. C. & Burnie, J. P. (1989). Cloning of a DNA sequence encoding a major fragment of the 47 kilodalton stress protein homologue of Candida albicans. FEMS Microbiology Letters 60, 25-30.
64. Merz, W. G., Karp, J. E , Hoagland, M., Jett-Goheen, M , Junkins, J. M & Hood, A. F. (1988). Diagnosis and successful treatment of fusariosis in the compromised host. Journal of Infectious Diseases 158, 1046-1055.
65. Meyers, J. D. & Atkinson, K (1983) Infection in bone marrow transplantation. Clinics in Haematology 12, 791-811.
66. Millon, L., Manteaux, A., Reboux, G., Drobacheff, C , Monod, M., Barale, T et al. (1994) Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients, persistence of Candida albicans strains with the same genotype. Journal of Clinical Microbiology 32, 1115-1118.
67. Mitchell, T. G., Freedman, E. Z., White, T. J. & Taylor, J. W. (1994). Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans. Journal of Clinical Microbiology 32, 253-255.
68. Mitchell, T. G. & Perfect, J. R. (1995). Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans. Clinical Microbiology Reviews 8, 515-548.
69. Moore, M. K. (1986) Hendersonula toruloidea and Scytalidium hyalinum infections in London, England Journal of Medical and Veterinary Mycology 24, 219-230.
70. Nelson, P E., Dignani, M. C. & Anaissie, E. J. (1994). Taxonomy, biology, and clinical aspects of Fusarium species. Clinical Microbiology Reviews 7, 479-504
71. Nolard, N., Detandt, M. & Beguin, H. (1968). Ecology of Aspergillus species in the human environment. In Aspergillus and Aspergillosis (ed. H. Vanden Bossche, D. W. R. Mackenzie & G. Cauwenbergh), pp 35-41. Plenum Press: New York.
72. Odds, F. C. (1993). Resistance of yeasts to azole-derivative antifungals. Journal of Antimicrobial Chemotherapy 31, 463-471.
73. Odds, F. C. & Abbott, A. B (1980). A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species. Sabouraudia 18, 301-317.
74. Oxford, A E., Raistrick, H. & Simonart, P. (1939). Studies in the biochemistry of micro-organisms 60. Griseofulvin, a metabolic product of Penicillium griseofulvum Dierckx. Biochemical Journal 33, 240-248.
75. Pannuti, C. S., Gingrich, R., Pfaller, M. A., Kao, C. & Wenzel, R. P. (1992). Nosocomial pneumonia in patients having bone marrow transplant. Cancer 69, 2653-2662
76. Paugam, A , Dupouy-Camet, J., Blanche, P., Gangneux, J. P., Tourte-Schaefer, C. & Sicard, D. (1994). Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clinical Infectious Diseases 19, 975-970.
77. Pfaller, M A. (1995) Epidemiology of fungal infections: the promise of molecular typing. Clinical Infectious Diseases 20, 1535-1539.
78. Pfaller, M. A., Rhine-Chalberg, J., Redding, S. W., Smith, J., Fannacci, G., Fothergill, A. W. & Rinaldi, M. G. (1994). Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. Journal of Clinical Microbiology 32, 59-64.
79. Phelan, J A , Saltzman, B. R., Friedland, G. H. & Klein, R. S. (1987). Oral findings in patients with acquired immunodeficiency syndrome. Oral Surgery, Oral Medicine and Oral Pathology 64, 50-56.
80. Philpott-Howard, J., Wade, J. J., Mufti, G. J., Brammer, K. W. & Ehrunger, G (1993). Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Journal of Antimicrobial Chemotherapy 31, 973-984.
81. Pont, A., Graybill, J R., Craven, P. C , Galgiani, J. N., Dismukes, W. E., Reitz, R. E. et al. (1984). High dose ketoconazole therapy and adrenal and testicular function in humans. Archives of Internal Medicine 144, 2150-2153.
82. Price, M. F., LaRocco, M. T. & Gentry, L. O. (1994). Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrobial Agents and Chemotherapy 38, 1422-1424
83. Reagen, D. R , Pfaller, M. A., Mollis, R J. & Wenzel, R P (1990). Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe Journal of Clinical Microbiology 20, 2733-2738
84. Remel, D. (1992). Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use. Dermatology 182, 21-24
85. Ruhnke, M., Eigler, A , Tennagen, I., Geisler, B., Engelmann, E. & Trautmann, M. (1994). Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Journal of Clinical Microbiology 32, 2092-2098.
86. Sangeorzan, J A , Bradley, S. F , He, X , Zarins, L T., Ridenour, G. L., Tiballi, R. N et al. (1994). Epidemiology of oral candidiasis in HIV-infected patients' colonization, infection, treatment and emergence of fluconazole resistance. American Journal of Medicine 97, 339-346.
87. Sanglard, D., Kuchler, K., Ischer, F , Pagani, J -L., Monod, M & Bille, J. (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrobial Agents and Chemotherapy 39, 2378-2386
88. Schaberg, D. R., Culver, D. H. & Gaynes, R. P (1991). Major trends in the microbial etiology of nosocomial infection American Journal of Medicine 91, supplement 3B, 72-75.
89. Scholer, H. & Polak, A. (1984). Resistance to systemic antifungal agents. In Antimicrobial Drug Resistance (ed. L. E. Bryan), pp. 393-460. Academic Press, Orlando.
90. Sherertz, R. J., Gledhill, K. S., Hampton, K. D., Pfaller, M. A., Givner, L. B., Abramson, J. S. et al. (1992) Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care until. Journal of Pediatrics 120, 455-461.
91. Smith, K. J , Warnock, D. W., Kennedy, C. T C , Johnson, E. M., Hopwood, V., Van Cutsem, J. et al. (1986). Azole resistance in Candida albicans. Journal of Medical and Veterinary Mycology 24, 133-144.
92. Strockbine, N A, Largen, M. T., Zweibel, S. M. & Buckley, H R. (1984). Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera. Infection and Immunity 43, 715-721.
93. Suppararpinyo, K., Khamwan, C , Baosoung, V., Nelson, K. E. & Sirisanthana, T. (1994). Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 344, 110-113.
94. Tang, C. M., Holden, D. W., Aufauvre-Brown, A. & Cohen, J. (1993). The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid. American Review of Respiratory Diseases 148, 1313-1317.
95. Troillet, N., Durussel, C., Bille, J., Glauser, M P. & Chave, J.-P. (1993). Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. European Journal of Clinical Microbiology and Infectious Diseases 12, 911-915
96. Vanden Bossche, H., Marichal, P. & Odds, F. C. (1994). Molecular mechanisms of drug resistance in fungi. Trends in Microbiology 2, 393-400
97. Voss, A., Hollis, R. J , Pfaller, M. A., Wenzel, R. P. & Doebbeling, B. N. (1994). Investigation of the sequence of colonization and candidemia in non-neutropenic patients. Journal of Clinical Microbiology 32, 975-980.
98. Walsh, T. J. & Dixon, D. M. (1989) Nosocomial aspergillosis environmental microbiology, hospital epidemiology, diagnosis and treatment. European Journal of Epidemiology 5, 131-142.
99. Walsh, T. J., Hathorn, J. W., Sobel, J D., Merz, W. G., Sanchez, V., Maret, M. et al. (1991). Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. New England Journal of Medicine 324, 1026-1031.
100. Warnock, D. W. (1991). Introduction to the management of fungal infection in the compromised patient. In Fungal Infection in the Compromised Patient (ed. D. W. Warnock & M. D. Richardson), 2nd edn., pp. 23-53. Wiley Chichester.
101. Warnock, D. W. & Johnson, E. M. (1991). Clinical manifestations and management of hyalohyphomycosis, phaeohyphomycosis and other uncommon forms of fungal infection in the compromised patient. In Fungal Infection in the Compromised Patient (ed. D. W. Warnock & M. D. Richardson), 2nd edn., pp 247-310. Wiley: Chichester.
102. Warnock, D. W., Speller, D. C. E., Day, J. K. & Farrell, A J. (1979). Resistogram method for differentiation of strains of Candida albicans. Journal of Applied Bacteriology 46, 571-578
103. Wheat, J (1995). Endemic mycoses in AIDS: a clinical review Clinical Microbiology Reviews 8, 146-159
104. Williams, D. I., Marten, R. H & Sarkany, I. (1958). Oral treatment of ringworm with griseofulvin. Lancet ii, 259-266.
105. Wingard, J. R., Merz, W. G , Rinaldi, M. G., Johnson, T R., Karp, J. E. & Saral, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole New England Journal of Medicine 325, 1274-1277.
106. Wingard, J R., Merz, W. G & Saral, R. (1979). Candida tropicalis: a major pathogen in immunocompromised patients. Annals of Internal Medicine 91, 539-543.
107. Winston, D J., Gale, R. P., Meyer, D. V. & Young, L S. (1979) Infectious complications of human bone marrow transplantation. Medicine 58, 1-31.